GERM vs. ARKG
GERM (Amplify Treatments, Testing and Advancements ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. GERM is passively managed, while ARKG is actively managed. Over the past year, GERM returned 0.00% vs 52.94% for ARKG. GERM charges 0.68%/yr vs 0.75%/yr for ARKG.
Performance
GERM vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ARKG
- 1D
- -1.25%
- 1M
- 18.68%
- YTD
- 25.65%
- 6M
- 18.88%
- 1Y
- 52.94%
- 3Y*
- 3.54%
- 5Y*
- -16.18%
- 10Y*
- 8.79%
GERM vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 25.65% | 23.04% | -5.71% |
GERM vs. ARKG - Sectors Allocation Comparison
Sectors
GERM
ARKG
Healthcare
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
GERM
ARKG
Financial Services
GERM
ARKG
Basic Materials
GERM
-
ARKG
-
Communication Services
GERM
-
ARKG
-
Consumer Cyclical
GERM
-
ARKG
-
Consumer Defensive
GERM
-
ARKG
-
Energy
GERM
-
ARKG
-
Industrials
GERM
-
ARKG
-
Real Estate
GERM
-
ARKG
-
Technology
GERM
-
ARKG
-
Utilities
GERM
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. ARKG — Risk / Return Rank
GERM
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
ARKG
GERM vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GERM | ARKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.22 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 1.93 | — |
| Martin ratioReturn relative to average drawdown | — | 4.60 | — |
Loading charts...
Drawdowns
GERM vs. ARKG - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for GERM and ARKG.
Loading charts...
Drawdown Indicators
| GERM | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -83.59% | +83.59% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | -27.51% | +27.51% |
Max Drawdown (3Y)Largest decline over 3 years | — | -51.96% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -80.18% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -83.59% | — |
Current DrawdownCurrent decline from peak | 0.00% | -67.43% | +67.43% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -36.00% | +36.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | 11.53% | -11.53% |
Volatility
GERM vs. ARKG - Volatility Comparison
The current volatility for Amplify Treatments, Testing and Advancements ETF (GERM) is 0.00%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 15.26%. This indicates that GERM experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GERM | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | 15.26% | -15.26% |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | 30.89% | -30.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 42.61% | -42.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 45.93% | -45.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 41.30% | -41.30% |
GERM vs. ARKG - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
GERM vs. ARKG - Dividend Comparison
Neither GERM nor ARKG has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKG has higher volatility (15.26%) compared to GERM (0.00%). In terms of maximum drawdown, GERM dropped 0.00% vs ARKG's -83.59%.
On 1-year performance, ARKG leads with 52.94% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, ARKG has performed better with a 52.94% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GERM is cheaper with a 0.68% expense ratio, compared with 0.75% for ARKG.
GERM and ARKG have nearly identical dividend yields, around 0.00%.
They also come from different issuers: Amplify and ARK. Their fees differ too: 0.68% for GERM and 0.75% for ARKG.
Find the right allocation for GERM and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer